|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,567.00 INR | +0.32% |
|
+1.25% | -1.57% |
| 30/01 | Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| 30/01 | Hester Biosciences Limited, Q3 2026 Earnings Call, Jan 30, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HESTER BIOSCIENCES LIMITED | Veterinary Drugs | +0.32% | +1.25% | -1.57% | -4.10% | -10.66% | 15Cr |
-
|
-
|
-
|
Technical Rankings Surperformance
- Stock Market
- Equities
- HESTERBIO Stock
- Charts Hester Biosciences Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition